Egea Biosciences

Egea Biosciences Overview

Founded 2000
Status Acquired/​Merged
Employees 40
Latest Deal Type M&A

Egea Biosciences General Information


Developer of protein drugs. The company's technology platform creates large libraries of proteins with directed single amino acid changes based on any imagined structure as programmed in a computer in order to revolutionize protein drug development and optimization.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 6759 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States

Egea Biosciences Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Egea Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 18-May-2004 Completed Startup
5. Grant 16-Jan-2004 00000 Completed Startup
4. Grant 31-May-2003 00000 Completed Startup
3. Grant 31-Jan-2002 00000 Completed Startup
2. Grant 28-Dec-2000 $317K Completed Startup
1. Early Stage VC 01-Jan-2000 Completed Startup

Egea Biosciences Former Investors (2)

To view Egea Biosciences‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hamilton BioVentures Venture Capital Minority 000 0000 000000 0
United States Army Government 000 0000 000000 0

Ready to get started?

Request a free trial